Form 4 for AXGN Axogen, Inc.
Accepted 2025-10-31 00:00:00 ET · period of report 2025-10-29 · accession 0000805928-25-000132 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-31 | 2025-10-29+ | AXGN | Burke William P. Mr. | Dir | S - Sale+OE | $21.32 | -58.5K | 100 | -100% | -$1.25M |
| DM | 2025-10-31 | 2025-10-29+ | AXGN | Burke William P. Mr. | Dir | M - OptEx | $7.15 | +58.5K | 18.3K | New | +$418.4K |
| DM | 2025-10-31 | 2025-10-29+ | AXGN | Burke William P. Mr. | Dir | M - OptEx | $0.00 | -58.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-29 | S | D | 20,436 | $19.15 | 100 | D | — | — | (F1) The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.50 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-10-29 | M | A | 20,436 | $6.30 | 20,536 | D | — | — | |
| 3 | Common | Common Stock | 2025-10-30 | S | D | 18,248 | $23.00 | 100 | D | — | — | (F2) The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. |
| 4 | Common | Common Stock | 2025-10-29 | M | A | 19,799 | $8.14 | 19,899 | D | — | — | |
| 5 | Common | Common Stock | 2025-10-30 | M | A | 18,248 | $7.04 | 18,348 | D | — | — | |
| 6 | Common | Common Stock | 2025-10-29 | S | D | 19,799 | $22.00 | 100 | D | — | — | (F2) The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. |
| 7 | Derivative | Stock Option (right to buy) | 2025-10-29 | M | D | 20,436 | $0.00 | 0 | D | $6.30 · — to 2033-09-01 | 20,436 Common Stock | (F3) This grant vested on the first anniversary of the date of the grant, September 1, 2023. |
| 8 | Derivative | Stock Option (right to purchase) | 2025-10-29 | M | D | 19,799 | $0.00 | 39,596 | D | $8.14 · — to 2032-07-11 | 19,799 Common Stock | (F4) This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022. |
| 9 | Derivative | Employee Stock Option (right to purchase) | 2025-10-30 | M | D | 18,248 | $0.00 | 0 | D | $7.04 · — to 2034-06-06 | 18,248 Common Stock | (F5) This grant vested on the first anniversary of the date of the grant, June 6, 2024. |